- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Dipeptidyl-Peptidase IV Inhibitors
Total 1754 results
-
Heart Care FoundationFondazione dell'Associazione Medici DiabetologiCompletedDiabetes Mellitus, Type 2 | Left Ventricular Systolic DysfunctionItaly
-
Unity Health TorontoCompletedHeart Failure | Diabetes Mellitus, Non-Insulin-DependentCanada
-
George Washington UniversityAstraZenecaCompletedType 2 DiabetesUnited States
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, New Zealand, Spain, Japan, Finland, Germany, Greece, Romania, South Africa, Denmark, Colombia, Poland, United Kingdom, Mexico, Australia, Belgium, Ireland
-
TakedaCompletedDiabetes Mellitus, Type 2United States
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusSweden, United States, Australia, Brazil, Czech Republic, Italy, Mexico, Peru, Poland, Russian Federation, South Africa, Spain, United Kingdom, Germany, China, Hungary, Netherlands, Canada, Hong Kong, Argentina, Chile, France, Israel, Puerto Rico and more
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Australia, Canada, Denmark, Netherlands, Sweden
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesKorea, Republic of, United Kingdom, Australia, Canada, Thailand, India
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesCroatia, United States, Bulgaria, Czech Republic, Poland, Russian Federation, Belarus, Estonia, Germany, Hungary, Latvia, Lithuania, Romania, Ukraine
-
AstraZenecaBristol-Myers SquibbCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Royal Devon and Exeter NHS Foundation TrustKing's College London; King's College Hospital NHS Trust; Newcastle University; Newcastle-upon-Tyne Hospitals NHS Trust and other collaboratorsCompleted
-
Janssen Research & Development, LLCCompletedCardiovascular Diseases | Diabetes Mellitus, Type 2United States
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2United States, France, Switzerland, Germany, South Africa, Korea, Republic of, Puerto Rico, Canada, Taiwan, Spain, Poland, Slovakia, Thailand, Mexico, Turkey, Australia, Greece, Norway, Sweden, Peru, Romania, Argentina, United Kingdom
-
AET Laboratories Private LimitedCompleted
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States, Germany
-
Fayoum UniversityBoehringer IngelheimCompletedDiabetes | Microalbuminuria | Kidney Function Affection Upon Exposure to RadiocontrastEgypt
-
Sichuan Provincial People's HospitalCompletedDiabetes MellitusChina
-
Sherif S. FaragNational Heart, Lung, and Blood Institute (NHLBI)CompletedLymphoma, Non-Hodgkin | Acute Myeloid Leukemia | Acute Lymphoid Leukemia | Leukemia, Myelogenous, Chronic | Hematopoetic MyelodysplasiaUnited States
-
Lawson Health Research InstituteThe Physicians' Services Incorporated FoundationTerminatedType 2 Diabetes | Nonalcoholic SteatohepatitisCanada
-
Shanghai Zhongshan HospitalChinese Medical AssociationCompleted
-
Seoul National University HospitalCompletedDiabetes Mellitus, Non-Insulin-DependentKorea, Republic of
-
Kyunghee University Medical CenterUnknown
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Washington University School of MedicineThe Campbell FoundationCompletedDiabetes | Insulin ResistanceUnited States
-
ikfe-CRO GmbHNovartis Pharmaceuticals; IKFE Institute for Clinical Research and DevelopmentUnknown
-
PhenomixForest LaboratoriesTerminatedType 2 Diabetes MellitusUnited States, Argentina, India, Peru, Poland, Czech Republic
-
National Taiwan University HospitalUnknown
-
University of ManchesterTerminatedHypoglycemia | DiabetesUnited Kingdom
-
October 6 UniversityRecruitingPoly Cystic Ovary SyndromeEgypt
-
TakedaCompleted
-
University Hospital MuensterCompletedSystemic Inflammatory Response SyndromeGermany
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States
-
Boehringer IngelheimCompletedHealthyRussian Federation
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Argentina, Belgium, Canada, China, Germany, Korea, Republic of, Philippines, Russian Federation, Taiwan, Turkey, United Kingdom
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Croatia, India, Israel, Italy, Malaysia, Netherlands, Poland, Romania, Slovakia, Thailand, Ukraine
-
University of Erlangen-Nürnberg Medical SchoolCompleted
-
AstraZenecaBristol-Myers SquibbCompleted
-
Boehringer IngelheimEli Lilly and CompanyActive, not recruiting
-
Oslo University HospitalVestre Viken Hospital Trust; University of Oslo; The Research Council of Norway; University Hospital, Akershus and other collaboratorsRecruitingGlucose Metabolism Disorders | Impaired Glucose Tolerance | Insulin SensitivityNorway
-
University of MiamiWithdrawn
-
Baylor College of MedicineTerminatedImpaired Glucose ToleranceUnited States
-
Emory UniversityTerminated
-
University of MinnesotaCompletedDiabetes | PancreatitisUnited States
-
TakedaCompleted
-
Postgraduate Institute of Medical Education and...Unknown
-
AstraZenecaCompletedType 2 DiabetesUnited States, Mexico, Puerto Rico, Israel, Sweden, Italy, Philippines, Argentina
-
Boehringer IngelheimCompleted